Multiple Sclerosis News Today

May 29, 2020May 29, 2020

Cell Therapy ATA188 Safely Easing Disability in Progressive MS, Trial Reports

COVID-19 News, Multiple Sclerosis News Today

Atara Biotherapeutics‘ cell-based therapy ATA188 is safe and well-tolerated in people with progressive forms of multiple sclerosis (MS), and induces a sustained reduction in disability in a dose-dependent manner, findings ... Read more

May 29, 2020May 29, 2020

Ofatumumab Lowers B-cell Counts and Helps Relapsing MS Patients Reach NEDA, Data Show

Multiple Sclerosis News Today

Ofatumumab (OMB157) elicits a strong and fast reduction in the levels of circulating immune cells in people with relapsing forms of multiple sclerosis (MS), effectively helping to stop disease activity, ... Read more

May 28, 2020May 28, 2020

MS Diagnostic Criteria Should Be Changed to First Rule Out NMOSD, Study Says

Multiple Sclerosis News Today

Diagnostic guidelines for multiple sclerosis (MS) should be amended to first rule out the presence of neuromyelitis optica spectrum disorder (NMOSD), a neurological inflammatory disease that also affects the brain ... Read more

May 27, 2020May 28, 2020

Zeposia Receives European Commission Approval for Adults with Active RRMS

Multiple Sclerosis News Today

The European Commission (EC) has approved Zeposia (ozanimod) for the treatment of adults with relapsing-remitting multiple sclerosis (RRMS) who have active disease based on clinical or imaging features. The EC ... Read more

May 27, 2020May 27, 2020

Higher Blood NfL Levels Predict Worse Disability Over Time in MS

Multiple Sclerosis News Today

Higher blood levels of the neurofilament light chain (NfL) protein at diagnosis are predictive of worse disability over time in people with multiple sclerosis (MS), a large population study from Sweden ... Read more

May 27, 2020May 27, 2020

Air Pollution of Urban Life Raises MS Risk, Study from Italy Suggests

Multiple Sclerosis News Today

Exposure to air pollutants, particularly to fine particle pollutants (2.5 micrometers or less in diameter), seems to increase a person’s risk of multiple sclerosis (MS), a study from northern Italy suggests. ... Read more

May 26, 2020May 26, 2020

New Drug Lowers MS Relapse Rates Over 2 Years, Trial Data Show

COVID-19 News, Multiple Sclerosis News Today

The oral medication evobrutinib leads to a sustained reduction in relapse rates in people with relapsing multiple sclerosis (MS), data from a Phase 2 extension trial show. These findings were ... Read more

May 26, 2020May 26, 2020

MS Association Makes COVID-19 Webinars, Other Resources Available

COVID-19 News, Multiple Sclerosis News Today

The Multiple Sclerosis Association of America (MSAA) is opening its resources to people with multiple sclerosis (MS) during COVID-19, including a webinar series on the pandemic and easier access to its ... Read more

May 22, 2020May 22, 2020

MedTech Breakthrough Cites RxMx and Roche for MS Patient App

Multiple Sclerosis News Today

For a comprehensive support app developed for multiple sclerosis (MS) patients, RxMx and Roche have won the Patient Engagement Innovation Award from Medtech Breakthrough. The fourth annual awards program recognized top health ... Read more

May 22, 2020May 22, 2020

Cell Transplant Restores Myelin Production in Brains of Adult Mice in MS Model

Multiple Sclerosis News Today

Human glial progenitor cells — forerunners of nerve cells that protect and support neurons — transplanted into adult mice in a model of multiple sclerosis (MS) were seen to restore ... Read more

May 21, 2020May 21, 2020

Higher Risk of Vascular Disease Among MS Patients in the UK, Population-based Study Reveals

Multiple Sclerosis News Today

People in the United Kingdom (U.K.) with multiple sclerosis (MS) have an increased risk of vascular disease affecting the heart and brain that is not accounted for by traditional disease ... Read more

May 21, 2020May 21, 2020

Learning Physical Task Seen to Trigger Myelin Repair in MS Mouse Model

Multiple Sclerosis News Today

Movements that are an act of “learning” motor tasks after lesions appear in the protective myelin sheath of neurons seem to induce both new and existing oligodendrocytes — the cells that ... Read more

May 20, 2020May 20, 2020

Biogen Presents Update on its MS Therapeutic Portfolio

COVID-19 News, Multiple Sclerosis News Today

Biogen has released new data on several of its therapies for multiple sclerosis (MS), including Vumerity (diroximel fumarate), Tecfidera (dimethyl fumarate), and Tysabri (natalizumab). The data — six presentations — ... Read more

May 20, 2020May 20, 2020

Glatopa Shows Efficacy Similar to Copaxone, Study in Real-world Use Finds

Multiple Sclerosis News Today

Glatopa, a generic form of Copaxone, is as effective as the brand-name medication in terms of disease outcomes and has similar healthcare-related costs in real-world use in patients with relapsing multiple sclerosis ... Read more

May 19, 2020May 19, 2020

MS Patients Have More Aluminum Content in Their Brains Than Those Without Neurodegenerative Conditions, Study Finds

Multiple Sclerosis News Today

People with multiple sclerosis (MS) and other neurological diseases have a significantly higher aluminum content in their brains than those with no known neurological impairment and no identifiable neurodegenerative disease, ... Read more